Try our beta test site
264 studies found for:    LEIOMYOMA, UTERINE
Show Display Options
Rank Status Study
1 Terminated Radiofrequency Ablation of Uterine Fibroids
Condition: Uterine Fibroids
Intervention: Procedure: radiofrequency ablation
2 Active, not recruiting High-intensity Focused Ultrasound in Treatment of Uterine Fibroid
Condition: Fibroids
Intervention: Procedure: HIFU treatment
3 Completed Fibroids in Women of Reproductive Age and Women Pregnancy
Condition: Fibroids
Interventions: Drug: Dydrogesterone M ( case 1 );   Drug: Dydrogesterone M ( case 2 )
4 Withdrawn Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
Condition: Leiomyomas
Interventions: Drug: Ulipristal Acetate;   Drug: Iron
5 Active, not recruiting Uterine Leiomyoma Treatment With Radiofrequency Ablation
Condition: Uterine Fibroids
Intervention: Device: Radiofrequency ablation of fibroids
6 Completed Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap
Condition: Leiomyoma
Interventions: Drug: BAY1002670;   Drug: Placebo
7 Completed Therapeutic MRI Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids
Condition: Uterine Leiomyomas
Intervention: Device: Philips MR-guided HIFU
8 Active, not recruiting Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
Condition: Uterine Fibroids
Intervention: Procedure: Radiofrequency ablation of fibroids
9 Terminated
Has Results
Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg;   Drug: Lupron Depot
10 Terminated Mifepristone to Treat Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Oral administration of mifepristone 2.5 mg daily for three months;   Drug: Oral administration of mifepristone 5 mg daily for three months
11 Terminated
Has Results
Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg
12 Completed Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: 12.5 mg Proellex;   Drug: 25 mg Proellex;   Drug: Placebo
13 Terminated
Has Results
Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex;   Other: placebo
14 Terminated
Has Results
Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex;   Drug: Placebo
15 Completed
Has Results
Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids
Conditions: Uterine Fibroids;   Uterine Myomas
Intervention: Device: Halt Procedure
16 Completed Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids
Condition: Leiomyoma
Interventions: Drug: Vilaprisan (BAY1002670);   Drug: Vilaprisan (BAY1002670;   Drug: Ulipristal
17 Completed A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
Condition: Uterine Leiomyomata
Interventions: Drug: Progenta;   Drug: Lucron Depot;   Drug: Placebo
18 Completed Fibroid Growth Study
Condition: Uterine Leiomyomas
Intervention:
19 Not yet recruiting Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization
Condition: Uterine Fibroids
Intervention: Procedure: Uterine Fibroid Embolization
20 Completed A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.
Condition: Leiomyoma
Intervention: Drug: Asoprisnil

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.